Lucie  Bruijn , Ph.D.

Lucie Bruijin, Ph.D., is science director and vice president of The Amyotrophic Lateral Sclerosis (ALS) Association. This national non-profit organization is the largest private source of funding for ALS-specific scientific research in the world, having awarded nearly $30 million since 1995. Dr. Bruijin received a bachelor's degree in pharmacy from Rhodes University, South Africa, and a master's degree in neuroscience and a doctorate in biochemistry at the University of London, United Kingdom. She has developed and characterized various model systems of neurodegenerative diseases, including one of the mouse models of ALS.